Equitable Life of Canada is implementing the Equitable Life Specialty Drug Management Program (SDMP) as an integral part of its drug plan management strategy.
The program aims to ensure appropriate use of specialty drugs, integration with other reimbursement avenues, reduction of out-of-pocket responses for plan embers, and drug plan sustainability.
Equitable Life is introducing this program for all pay-direct drug and reimbursement plans. It will apply to select high-cost specialty drugs used for a variety of medical conditions, such as multiple sclerosis, inflammatory diseases, rare diseases and cancer.
The probability of a specialty drug claim per 1,000 certificates has increased more than 100% since 2008, according to Equitable Life figures.